about
Canadian clinical practice guidelines for the management of anxiety, posttraumatic stress and obsessive-compulsive disordersNanotoxicity overview: nano-threat to susceptible populationsPharmacokinetics and intramuscular bioavailability of a single dose of butorphanol in Asian elephants (Elephas maximus)Cardiac safety of ophthalmic timolol.Impact of antiepileptic drugs on thrombocytopenia in glioblastoma patients treated with standard chemoradiotherapy.Interindividual variability in hepatic drug glucuronidation: studies into the role of age, sex, enzyme inducers, and genetic polymorphism using the human liver bank as a model system.Factors influencing pharmacokinetics of prophylactic posaconazole in patients undergoing allogeneic stem cell transplantationHealthcare maintenance in elderly patients with inflammatory bowel disease.Long-acting nanoformulated antiretroviral therapy elicits potent antiretroviral and neuroprotective responses in HIV-1-infected humanized mice.Evaluation of the safety and efficacy of pregabalin in older patients with neuropathic pain: results from a pooled analysis of 11 clinical studiesLipoic Acid Pharmacokinetics at Baseline and 1 year in Secondary Progressive MS.Age and gender dependent bioavailability of R- and R,S-α-lipoic acid: a pilot study.Influence of regular physical activity on warfarin dose and risk of hemorrhagic complications.Combination of micellar electrokinetic and high-performance liquid chromatographies to assess age-related changes in the in vitro metabolism of Fischer 344 rat liver.Energy restriction does not compensate for the reduced expression of hepatic drug-processing genes in mice with aging.Polypharmacy in the HIV-infected older adult population.Age-related changes in plasma concentrations of the HIV protease inhibitor lopinavir.Medication and fall injury in the elderly population; do individual demographics, health status and lifestyle matter?Safety of gastroenterologist-guided sedation with propofol for upper gastrointestinal therapeutic endoscopy in elderly patients compared with younger patients.The effect of age on the discriminative stimulus effects of ethanol and its GABA(A) receptor mediation in cynomolgus monkeys.Age-related changes in the hepatic pharmacology and toxicology of paracetamol.Pharmacokinetics of orally administered uracil in healthy volunteers and in DPD-deficient patients, a possible tool for screening of DPD deficiency.Therapeutic paracetamol treatment in older persons induces dietary and metabolic modifications related to sulfur amino acids.Use of antiarrhythmic drugs in elderly patientsSpecial population considerations and regulatory affairs for clinical researchAge-related changes in slow wave activity rise time and NREM sleep EEG with and without zolpidem in healthy young and older adultsPopulation-based input function and image-derived input function for [¹¹C](R)-rolipram PET imaging: methodology, validation and application to the study of major depressive disorderPharmacokinetics of Selected Anticancer Drugs in Elderly Cancer Patients: Focus on Breast Cancer.Sedation in gastrointestinal endoscopy: current issuesEffect of anticholinergic use for the treatment of overactive bladder on cognitive function in postmenopausal womenUnique Aspects of the Elderly Surgical Population: An Anesthesiologist's PerspectivePharmacokinetics of two common antiretroviral regimens in older HIV-infected patients: a pilot study.Effects of age and sex on the pharmacokinetics of the soluble guanylate cyclase stimulator riociguat (BAY 63-2521)Clinical pharmacokinetics of antiretroviral drugs in older persons.Stepwise sedation for elderly patients with mild/moderate COPD during upper gastrointestinal endoscopy.Effect of age on the pharmacokinetics of polymorphic nimodipine in rats after oral administrationRisk assessment of shellfish toxins.Drug utilization pattern and pharmacoeconomic analysis in geriatric medical in-patients of a tertiary care hospital of India.Factors affecting the development of adverse drug reactions (Review article)Evaluation of the Prevalence of Chronic Kidney Disease and Rates of Oral Antidiabetic Prescribing in Accordance with Guidelines and Manufacturer Recommendations in Type 2 Diabetic Patients within a Long-Term Care Setting.
P2860
Q27009995-EE43A63B-1BDE-4E04-8496-F9C142C99CA5Q28383369-79903391-A6FA-42EE-B28E-27EC9AC803AEQ28660744-5CD472F2-6568-41BC-95A4-EB7E0CB159ABQ33167596-6E60D673-4BCA-4B83-A2F9-30F0167E506EQ33400189-781741D9-C554-417D-B1CE-5590CD47C866Q33451969-AB5DD0FE-8503-4739-962B-29BA48D31F76Q33559111-0971EF49-B2B0-4B8F-87EC-1746001E1BFCQ33621700-292306E9-46B6-41BA-B211-A8CD9DCFBDFEQ33625213-EEF9A95F-7037-49A1-B178-EB766E8F20FDQ33739953-8F487C29-91B8-4DE2-AF28-7D0E81506357Q33848862-A385142E-5377-4813-9BED-31C8C32CB20DQ33854686-C820F82F-D67B-4267-AD10-328D45056939Q33943678-EFF27F9E-0866-4A1B-B21D-E2842B7B4C6DQ33957499-EF500EF8-37BC-4DC6-8875-A11894BC2B00Q34015647-6D238EF0-7D2C-4FE3-AD1F-3CC1239B9D6FQ34037407-2DDEB4A3-897B-47A2-87B0-D0C31B71C2B7Q34100187-FC7D3EBE-F9FA-4738-ABEF-4ACFD528C6E2Q34112914-FCF4BF79-DACF-4C79-A485-ADA569EEB5CBQ34809336-138575FA-DB28-46C8-90EA-30ECBF574849Q35098727-2B05480C-0E9E-4756-9C4E-708CB2E5C5BAQ35101500-697DCB73-BCE6-433C-92C7-0F4A28C396AAQ35563540-02552CDE-938C-4341-8B7A-0B8ED17C7AA7Q35678098-B1310729-E569-4D40-8F42-BB41D3CF6764Q36077245-5C199076-A0FD-4974-A563-CD8D001A6EE8Q36078698-400725DD-40FE-44BC-9391-66532A138BFBQ36191490-A740FD92-FDE3-4AB3-B248-097AE3BABA8CQ36319736-EB89374B-CFC3-493F-8F29-1A726A07A712Q36506987-2CCE4FF7-DE12-4EDA-9AE0-EA4D7B445EFEQ36572476-7CD7EA3C-6E99-4977-B198-1729F75E0B1AQ36611322-193A775F-CA5A-4096-9214-2428E7C639E4Q36684000-DF131F0D-ACF5-48DF-A56F-C8DAE0D8B163Q36876279-CFD19C1D-FACE-4A5D-A6E2-63401F73CC11Q36881692-C60796DC-2FC8-4538-A614-2EA806F1A849Q36905884-E6CE68E9-C945-4634-8EAF-9D6E8CB6F4E6Q37068289-13B4FFD3-0F30-4BF6-B4E6-35680A1F8CA2Q37302182-95A417F7-8D09-423E-8041-46AAD717646AQ37357875-81640843-4ABE-4E37-90DE-F4A1267D2E36Q37565856-B7F4705E-ABEF-468D-9DFC-10776DAC5C8EQ37631543-BDA0F4D5-4557-47B8-B0EE-F029DBF7A973Q37639812-84E3927A-B8F5-472E-8F84-2BAA517B07A6
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Pharmacokinetics and drug metabolism in the elderly.
@en
Pharmacokinetics and drug metabolism in the elderly.
@nl
type
label
Pharmacokinetics and drug metabolism in the elderly.
@en
Pharmacokinetics and drug metabolism in the elderly.
@nl
prefLabel
Pharmacokinetics and drug metabolism in the elderly.
@en
Pharmacokinetics and drug metabolism in the elderly.
@nl
P2860
P1476
Pharmacokinetics and drug metabolism in the elderly.
@en
P2093
Ulrich Klotz
P2860
P356
10.1080/03602530902722679
P407
P577
2009-01-01T00:00:00Z